Reblozyl 25 mg powder for solution for injection
- Licence status
- Active substances
- Luspatercept
- Dosage Form
- Powder for solution for injection
- Licence number
- EU/1/20/1452/001
- Licence holder
- Bristol-Myers Squibb Pharma EEIG
Product documents
Licence information
- ATC code
- B03XA06 luspatercept
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 25/06/2020